Seattle Children's Therapeutics (SCTx)
@SCTherapeutics
Followers
413
Following
609
Media
27
Statuses
290
A nonprofit therapeutics development enterprise devoted to envisioning and testing next-generation cell and gene therapies for pediatric diseases. #CARTcells
Seattle
Joined October 2020
Read the latest manuscript from Dr. Jacob Applebaum, research fellow and attending physician @fredhutch, and in collaboration with Seattle Children’s Therapeutics, highlighting drug-regulated CD33-targeted #CARTCells, recently published @jclinicalinvest.
0
1
4
Children with #lupus face a lifetime of serious health complications. Dr. @Shaun_W_Jackson's hope is that one day #CARTcell therapy may help patients with lupus achieve complete remission.
kuow.org
The U.S. Food and Drug Administration has given Seattle Children’s the green light to conduct a clinical trial for a drug that researchers hope can help fight pediatric lupus.
0
2
3
Some exciting news from Seattle Children's. Looking forward to working with @SCTherapeutics to lead the first US clinical trial of anti-CD19 CAR T cells in childhood-onset SLE. @seattlechildren
We are proud to announce Seattle Children’s has received @US_FDA authorization to launch the first chimeric antigen receptor (CAR) T-cell clinical trial in the U.S. for children under 18 with the most common form of lupus. https://t.co/oFmH2p5uT5
3
7
25
We are proud to announce Seattle Children’s has received @US_FDA authorization to launch the first chimeric antigen receptor (CAR) T-cell clinical trial in the U.S. for children under 18 with the most common form of lupus. https://t.co/oFmH2p5uT5
1
8
20
People with autoimmune disorders don’t usually get to talk about a cure. But a small new study is raising hopes CAR-T therapy could one day change that.
statnews.com
People with autoimmune disorders don’t usually get to talk about a cure. But a small new study is raising hopes CAR-T therapy could one day change that.
0
2
10
Continuing some great reporting from @isabellacueto and @angRchen over the last couple years, I wrote about a small, new study on the big potential for CAR-T therapy in autoimmune disorders:
statnews.com
People with autoimmune disorders don’t usually get to talk about a cure. But a small new study is raising hopes CAR-T therapy could one day change that.
0
6
8
Seattle Children’s Brain Tumor Program gives your child access to some of the most advanced treatments and clinical trials of any children’s hospital in the country. 🧡 https://t.co/WhNJjzwNR9
0
2
12
As one of the largest and most comprehensive pediatric brain tumor programs in the world, Seattle Children’s has specialists to cover every aspect of your child’s care. Learn more: https://t.co/WhNJjzwNR9
0
3
13
We love to show visitors where the magic happens. In our #CureFactory, we specialize in translating laboratory discoveries into real-world treatments.
The day ends with a tour of @SeattleChildren's Research Institute’s #CureFactory, led by two @WSU alumnae, and a lovely dinner with the WSU Board of Regents and members from the Seattle Children’s Foundation Board. #gocougs
0
1
7
Seattle Children’s neurosurgeons perform significantly more brain tumor operations on children than any other hospital in the region. Learn more: https://t.co/WhNJjzwNR9
1
1
10
A decline in cancer deaths is promising, yet more work is necessary. This is especially true for children and teens, as cancer remains the 2nd most common cause of death among children and 4th most common cause of death among adolescents in the US. Our work will continue until we
It’s here! The latest @AmericanCancer statistics report reveals that 4.1 million deaths from cancer have been averted since 1991, largely due to reductions in smoking and improvements in treatment and early detection. Read the free report: https://t.co/oFIZKFf4nY
@OncoAlert
0
1
5
Congress is once again racing against the clock to pass a Continuing Resolution and avert a shutdown. As #ChildhoodCancer advocates, we know that robust, predictable, and sustained funding for the NIH and NCI is critical for continued progress in the fight against cancer.
1
3
4
Seattle Children’s continues to be committed to building pathways into pediatric biomedical research through its successful summer internship program for undergraduate students. Submit your application to our Summer Scholars Program by Jan. 12. https://t.co/8KiwGkMrDP
0
6
16
2023 was an eventful year at Seattle Children’s Therapeutics. Check out our year in review for a few of our key milestones and recent achievements. 🔬 https://t.co/UDoDXcNHye
0
0
4
Colleen E. Annesley, MD, (@SCTherapeutics) discussed challenges with manufacturing T-APCs, assessing the cell therapy in clinical trials, and improving access to these kinds of therapies. #celltherapy #leusm #leukemia #ASH23 Read more: https://t.co/sn1bXTJedf
cgtlive.com
The medical Director and interim co-Chief Medical Officer at Seattle Children's Therapeutics discussed possible research to move forward with CD19 T-APCs for patients with B-ALL.
0
1
1
The use of CD19t T-APCs (manufactured T cells with a CD19 tag antigen presenting cells) after SCRI-CAR19 in patients treated for relapsed, refractory CD19+ B-cell acute lymphocytic #leukemia was well tolerated and appeared to enhance CAR T-cell persistence, Dr. Colleen Annesley
0
3
8
Seattle Children’s has launched BrainChild Bio to accelerate cures for kids through the advancement of pediatric chimeric antigen receptor #CARTcell therapies in Central Nervous System (CNS) tumors. https://t.co/A5K6zpZrdJ
1
4
13